Synthesis of phenyloxyisobutyric acid derivatives and their antidiabetic activity in vitro
- Author:
- No author available
- Journal Title:
- ACTA PHARMACEUTICA SINICA
- Issue:
- 2
- DOI:
- 10.3321/j.issn:0513-4870.2006.02.003
- Key Word:
- 胰岛素增敏剂;抗糖尿病活性;苯氧异丁酸类化合物;3T3-L1脂肪细胞;GOD-POD方法;insulin sensitizers;antidiabetic activity;phenyloxyisobutyric acid derivatives;3T3-L1adipocytes;GOD-POD method
Abstract： Aim To design and synthesize new phenyloxyisobutyric acid analogues as antidiabetic compounds. Methods Eight new target compounds were synthesized by combination of lipophilic moieties and acidic moiety with nucleophilic replacement or Mitsunobu condensation. The eight compounds were confirmed by 1H NMR, 13C NMR, IR and MS. Results In vitro insulin-sensitizing activity (3T3-L1adipocyte) demonstrated, that the cultured glucose concentration of up-clear solution detected with GODpioglitazone, compounds A and B were added to the insulin-resistant system. Conclusion In vitro insulin-sensitizing activity of target compound A is in between that of rosiglitazone and pioglitazone, and activity of target compound B is slightly less than that of pioglitazone.
- [1]黄莺,张惠斌,周金培,等.以PPAR为靶点的抗糖尿病药物研究[J].2004,(5).
- [2]汤磊,杨玉社,嵇汝运.抗糖尿病药物研究进展[J].2001,(9).
- [3]B C, Cantello,M A, Cawthorne,G P, Cottam,etc.[[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.[J].1994,37(23).
- [4]Jan Fleckner,Soren V. Lehmann,Helle F. Woldike,etc.Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity[J].2002,45(4).
- [5]Grossman, L.D..New Solutions for Type 2 Diabetes Mellitus: The Role of Pioglitazone.[J].2002,20(1).
- [6]Melvin S. Newman,James A. Cella.Monoalkylation of hydroquinone[J].1974,39(2).
- [7]Willson TM,Brown PJ,Sternbach DD,etc.The PPARs: from orphan receptors to drug discovery.[J].2000,43(4).
- [8]Kliewer SA,Orband-Miller LA,Oliver W Jr,etc.N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.[J].1998,41(25).
- [9]A.I. Graul.Compendium of Endocrine and Metabolic Drugs[J].2003,28(10).
- [10]P D, Davis,L H, Elliott,W, Harris,etc.Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity.[J].1992,35(6).